Skip to content

Psilocybin: A brief overview for psychiatric mental health nurse practitioners

Dina Fradkin

Perspectives In Psychiatric Care June 8, 2021 DOI: 10.1111/ppc.12888 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics Anxiety Psilocybin
Keywords Hallucinogen Modalities Mental health care Depression economics Psychotherapist Nursing
Citations 3
Key findings Psilocybin shows relative safety and potential efficacy for treating psychiatric disorders, and psychiatric mental health nurse practitioners must understand its principles to deliver care.

Abstract

The use of psychedelics, such as psilocybin, has emerged in recent literature as a novel therapeutic treatment for various psychiatric disorders, including substance use, depression, and anxiety. While international and domestic trials are currently underway, there is data demonstrating both the relative safety and potential efficacy of psilocybin. Psychiatric mental health nurse practitioners are essential mental health providers that may be at the forefront of delivering these new treatment modalities. Therefore, they must be aware of the psychopharmacological and psychotherapeutic tenets of psilocybin to be prepared to treat patients.

Explore topics